Shares of Orchid Pharma today
zoomed almost 20 per cent after the company said it has
received establishment inspection report (EIR) from the US
health regulator for its Alathur facility in Tamil Nadu.
The stock skyrocketed 19.83 per cent to settle at Rs
21.45 -- its highest trading permissible limit for the day --
On NSE, shares of the company soared 19.94 per cent to
end at Rs 21.35.
The company has received EIR from the United States Food
and Drug Administration (US FDA) based on the successful
inspection of the active pharmaceutical ingredients (API)
manufacturing facility at Alathur, Orchid Pharma said in a
The facility was inspected by the US FDA in May 2017, it
(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)